Cole Schmidtknecht had chronic asthma since he was a child, and had used a steroid inhaler to control his symptoms for more ...

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...

After UnitedHealthcare's drug arm jacked up the price of inhalers, a young man with severe asthma had to go without — and ...

Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.

Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...

The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...

The cost of Cole Schmidtknecht’s asthma inhaler was raised to over $500. His parents said Cole chose rent over medicine. Days ...

The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...

Trunk, a partner at Kline & Specter, alleged OptumRx and Cole’s pharmacy, Walgreens, are at fault in Cole’s death. “Our hope is that this lawsuit and Cole’s death will lead them to kind of ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...